CanSino's Inhaled COVID-19 Vaccine gets Emergency Use Approval in China
- Aryaman Sinha
- Sep 5, 2022
- 1 min read
China's CanSino Biologics Inc (6185.HK) said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business. Awesome!
Photo Credit: Li Yang
コメント